
RKO is a poorly differentiated colon carcinoma cell line developed by Michael Brattain.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use








Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?